Navigation Links
Dennis L. Smith Appointed Executive Chairman to Board of Directors of Solstice Neurosciences, Inc.
Date:10/11/2007

MALVERN, Pa., Oct. 11 /PRNewswire/ -- Solstice Neurosciences, Inc. ("Solstice") announced the appointment of Dennis L. Smith to its Board of Directors. Mr. Smith will serve as Executive Chairman replacing James Thomas, who remains on the Board having served as Chairman since Solstice was founded in July 2004.

Mr. Smith brings unique specialty pharmaceutical industry experience and expertise to Solstice that will be invaluable in providing guidance and leadership for growth and maximizing stockholder value. Mr. Smith will work with the Board and Solstice management to review current operations and develop strategic options.

Mr. Smith has worked in the pharmaceutical industry since 1973, and most recently served as President and Chief Executive Officer of INO Therapeutics LLC., a specialty pharmaceutical company with strengths in development, marketing, and sales of critical care drugs and drug/device combinations, and focused on making innovative therapies available to healthcare professionals and patients. Prior to INO, Mr. Smith spent 15 years with DuPont Pharmaceutical Company, where he served as President of U.S. Operations, Executive Vice President of Global Health Systems, Executive Vice President in Europe, and Vice President and General Manager in Canada, among numerous other positions at DuPont Pharmaceuticals and DuPont Merck. Mr. Smith was also employed at Baxter International and Sandoz Pharmaceuticals (now Novartis). Mr. Smith is a graduate of Michigan State University and the Lake Forest Graduate School of Business.

"We are extremely pleased to have Dennis join the Board of Directors of Solstice," said Shawn Patrick O'Brien, President and Chief Executive Officer. "His wide-ranging experience in the biopharmaceutical industry will undoubtedly prove to be extremely valuable as Solstice continues to evolve and broaden our product portfolio globally," Mr. O'Brien said.

"I am excited to be joining the Board and eager to work wi
'/>"/>

SOURCE Solstice Neurosciences, Inc.
Copyright©2007 PR Newswire.
All rights reserved

Page: 1 2

Related biology technology :

1. Local meteorology company accurately predicts Hurricane Dennis landfall
2. CIO Leadership Series: Greg Smith, Wheaton Franciscan Healthcare
3. GenTel acquires GlaxoSmithKline chip platform
4. Can you keep ahead of progress? An exclusive interview with Rick Smith of iNoc
5. VanderSanden appointed president of AT&T Wisconsin
6. Chemical-petroleum executive joins Virent Energy board
7. Visions: Matheys says CIO role is good training for executive suite
8. Biotech executive books a career flight thats closer to home
9. CEOs Gone Wild? Risks and rewards in the executive suite
10. Early-stage executives hear from investors
11. Pedlar the latest executive to leave Merge
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/23/2014)...  Sangamo BioSciences, Inc. (NASDAQ: SGMO ) ... accomplishments. For the second quarter ended ... of $7.0 million, or $0.10 per share, compared to ... share, for the same period in 2013. As of ... marketable securities and interest receivable of $236.7 million. ...
(Date:7/23/2014)... ANGELES , July 23, 2014 /PRNewswire-iReach/ -- Think ... cognitive performance for the long term. They are the ... edge of sustained energy as an alternative to the ... Think Drinks on Indiegogo on July 29, 2014, with ... 30-day campaign. Photo - http://photos.prnewswire.com/prnh/20140723/129697 ...
(Date:7/23/2014)...  Having the right people at the table for ... growth and achieving clinical and operational goals. The 22 ... July 20-22, 2014, in San Diego ... healthcare experts discussing how partnerships have positively impacted their ... Chief Executive Officer of Cape Regional Medical Center located ...
(Date:7/23/2014)... (PRWEB) July 23, 2014 DuPont Pioneer ... business as vice president of Agricultural Biotechnology (ABT), effective ... where he served most recently as president, chief executive ... and business leadership in the seed and crop protection ... Paul E. Schickler , president of DuPont Pioneer. ...
Breaking Biology Technology:Sangamo BioSciences Reports Second Quarter 2014 Financial Results 2Sangamo BioSciences Reports Second Quarter 2014 Financial Results 3Sangamo BioSciences Reports Second Quarter 2014 Financial Results 4Sangamo BioSciences Reports Second Quarter 2014 Financial Results 5Sangamo BioSciences Reports Second Quarter 2014 Financial Results 6Sangamo BioSciences Reports Second Quarter 2014 Financial Results 7Sangamo BioSciences Reports Second Quarter 2014 Financial Results 8Sangamo BioSciences Reports Second Quarter 2014 Financial Results 9truBrain Neuroscientists To Launch More Effective, Healthier Alternative To Energy Drinks On Indiegogo 2MSC and Cape Regional Medical Center Partner to Improve Cost, Quality and Outcomes 2DuPont Pioneer Names Neal Gutterson to Lead Agricultural Biotechnology 2DuPont Pioneer Names Neal Gutterson to Lead Agricultural Biotechnology 3
... Testing Management " Conference, Sept 23-25, that the American Filtration ... be seven short courses on September 22, 2008. Two of ... , ... Richfield, MN (PRWEB) August 8, ...
... ISELIN, N.J., Aug. 7 Pharmos Corporation,(Nasdaq: PARS ) ... The Company recorded a net loss of $2.7 million, or ... net loss of $4.6 million, or,$0.18 per share, in the ... June 30, 2008., The decrease in net loss for ...
... SOUTH SAN FRANCISCO, Calif., Aug. 7 Anesiva,Inc. (Nasdaq: ... the second quarter and six months ended June 30, ... advance for Anesiva as we,introduced Zingo(TM) in the U.S. ... executive officer. "In addition, I,m pleased,to report that our ...
Cached Biology Technology:Microfiltration Membrane and Ultrafiltration Membrane Training 2Microfiltration Membrane and Ultrafiltration Membrane Training 3Pharmos Corporation Reports 2008 Second Quarter Results 2Pharmos Corporation Reports 2008 Second Quarter Results 3Pharmos Corporation Reports 2008 Second Quarter Results 4Pharmos Corporation Reports 2008 Second Quarter Results 5Anesiva Announces Second Quarter 2008 Financial Results and Update 2Anesiva Announces Second Quarter 2008 Financial Results and Update 3Anesiva Announces Second Quarter 2008 Financial Results and Update 4Anesiva Announces Second Quarter 2008 Financial Results and Update 5Anesiva Announces Second Quarter 2008 Financial Results and Update 6Anesiva Announces Second Quarter 2008 Financial Results and Update 7Anesiva Announces Second Quarter 2008 Financial Results and Update 8
(Date:7/23/2014)... 2014 BCC Research ... GLOBAL MARKETS AND TECHNOLOGIES FOR SENSORS , the global ... grow to nearly $154.4 billion by 2020, with a ... image, flow, and level sensors segment is moving at ... http://photos.prnewswire.com/prnh/20140723/694805 ) , Sensors have become indispensable ...
(Date:7/23/2014)... Streptococcus mutans , one of the principal bacteria ... in its genetic material over time, possibly coinciding ... humanity. This is highlighted in a study ... (UAB) and the Laboratorio Nacional de Genmica para ... in Mexico who, for the first time, have ...
(Date:7/23/2014)... no cure exists for Alzheimer,s disease, the devastating ... But scientists are now reporting new progress on ... treatment, that shows promise as a potential oral ... Journal of Medicinal Chemistry . , Carlo ... in a healthy brain, the protein known as ...
Breaking Biology News(10 mins):Global Market for Sensors to Reach Nearly $154.4 Billion in 2020; Image Sensors Moving at 11.7% 2Global Market for Sensors to Reach Nearly $154.4 Billion in 2020; Image Sensors Moving at 11.7% 3Ancient genetic material from caries bacterium obtained for the first time 2
... Antarctic ice shelves to shrink and split apart, yielding thousands ... a new study in this week’s journal Science these floating ... miles across – are having a major impact on the ... ocean life, with thriving communities of seabirds above and a ...
... biofactories for the production of various beneficial human drugs, ... into mushrooms. , "There has always been a recognized ... for the mass production of commercially valuable proteins," said ... Chair in spawn science and professor of plant pathology ...
... Research Hospital have discovered how a single molecular “on switch” ... and memory capabilities to glucose production in the liver. ... transcription factor—a molecule that binds to a section of DNA ... specific protein for which it codes. CREB activates genes in ...
Cached Biology News:Antarctic icebergs -- Hotspots of ocean life 2Antarctic icebergs -- Hotspots of ocean life 3Modified mushrooms may yield human drugs 2St. Jude study shows genes play an unexpected role in their own activation 2
Anti-20S proteasome subunits alpha 1, 2, 3, 5, 6 & 7, clone MCP231 Immunogen: Dinitrophenylated proteasomes Molecular Weight: 29 and 32 kDa....
Anti-ADP-Ribosylation Factor 1, clone 3F1 Immunogen: Synthetic peptide corresponding to the C-terminal amino acid sequence of human ARF1. Available Date: 38495...
Myeloid Marker (BM-1)...
Request Info...
Biology Products: